Predict your next investment

Cardea Bio company logo
ELECTRONICS | Chips & Semiconductors / Semiconductors: Sensors
cardeabio.com

See what CB Insights has to offer

Founded Year

2013

Stage

Series A - IV | Alive

Total Raised

$21.8M

Last Raised

$6.5M | 1 yr ago

About Cardea Bio

Cardea Bio is a commercial manufacturer and developer of graphene-based digital biosensor hardware, software, and molecular infrastructure. The Cardea infrastructure enables application of advanced biosensors to any biological system, making the technology the ideal conduit to enable the future Internet of Biology.

Cardea Bio Headquarter Location

9640 Towne Centre Dr. Suite 100

San Diego, California, 92121,

United States

619-762-1142

Latest Cardea Bio News

11:00 ET Cardea Bio announces a collaboration agreement with Siemens Healthineers to assess feasibility of real-time application...

Jan 10, 2022

News provided by Share this article Share this article SAN DIEGO, Jan. 10, 2022 /PRNewswire/ -- Today, Cardea Bio, Inc. - the world's only mass producer of biocompatible semiconductors - announced a collaboration agreement with Siemens Healthineers' Center for Innovation in Diagnostics (CID) to assess feasibility of developing real-time biosensor applications using Cardea's BPU™ (Biosignal Processing Unit) Platform. Cardea's BPU™ Platform The technical teams from Siemens Healthineers and Cardea will work side-by-side optimizing and testing the capabilities of a next generation SARS-CoV-2 immunoassay. This includes transferring hardware, software, wetware and know-how to Siemens Healthineers facilities for their hands-on use and experimentation with Cardea's BPU™ Platform. If successful, Siemens Healthineers and Cardea have ambitions to potentially expand their collaboration to other areas which may include simultaneous measurement of antigen and amplification-free RNA detection to demonstrate the combined power of PCR-level sensitivity and speed of immunoassays in a single test. CEO of Cardea, Michael Heltzen, adds, "We're very humbled and proud that Siemens Healthineers has identified the transformational capabilities that our BPU™ Platform can bring to several areas across their existing and future product portfolios, and we look forward to the opportunity of realizing the potential of our technology together with the impressive team at Siemens Healthineers that has product development and marketing capabilities like few others in the world." Senior Vice President and Head of the CID at Siemens Healthineers, Rangarajan Sampath, PhD continues, "My team was impressed by Cardea's scientific and technical teams with world-class experience and a significant number of peer-reviewed publications, giving us every confidence that Cardea can realize desired products across multiple markets." Chief Business Officer at Cardea, Rob Lozuk, states, "Our commercial partners will allow the world to see the immediate benefits of Cardea's BPU™ Platform now and in the years to come by bringing 'Powered by Cardea' solutions to their respective markets. Our BPUs are not siloed to any one industry. Anywhere there is life; nature; biology; BPUs can be used to gain valuable insights - and the ultimate goal of this project together with Siemens Healthineers is creating a multiomics diagnostic platform for point-of-care use cases." About Cardea Cardea Bio, Inc. is the world's only mass producer of biocompatible semiconductors, the BPU™ (Biosignal Processing Unit). The BPU is the first and only semiconductor capable of translating real-time streams of multiomics signals into digital information. Through the BPU™ platform, Cardea's long-term vision is to democratize access to the biosignals and insights behind the most advanced technology on our planet: Nature and biology. The Internet of Biology is that way becoming possible. Cardea is headquartered in San Diego and has additional activity in Los Angeles. Cardea is a 100% American developed and built biocompatible semiconductor technology for applications across a variety of sectors including human health, agriculture, molecular diagnostics, biotechnology, environmental monitoring, and animal health. Contact Cardea US phone: +1 858 319 7135 EU phone: +45 2758 2601

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cardea Bio

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cardea Bio is included in 5 Expert Collections, including Omics.

O

Omics

1,213 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

A

Advanced Materials

1,228 items

Startups developing new or improved materials (chemicals, alloys, etc.) that provide physical or functional advantages to basic materials.

M

Medical Devices

242 items

Medical Device New Products & Services Tech MM (August 2021)

H

Health Monitoring & Diagnostics

701 items

Companies developing technology to facilitate near-patient and point-of-care (POC) in vitro diagnostic testing. Companies tagged as #NearPatient&POCTesting

D

Digital Health

12,248 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Cardea Bio Patents

Cardea Bio has filed 8 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • Biotechnology
  • DNA
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/21/2017

1/4/2022

Molecular biology, DNA sequencing, DNA, Genetics, Biotechnology

Grant

Application Date

8/21/2017

Grant Date

1/4/2022

Title

Related Topics

Molecular biology, DNA sequencing, DNA, Genetics, Biotechnology

Status

Grant

Cardea Bio Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Cardea Bio Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.